Investigations have shown that post-irradiation medication with various antibiotics has increased survival through reduction of the infection which follows acute whole body exposure to ionizing radiation ( 1-9). Miller et al. (9) have pointed out that not all antibiotics are effective because they could not control infections with Pseudomonas, Proteus or Salmonella. Recently Stavely ( 10) stated that the broad spectrum antibiotic JM-57h was effective against the above organisms so we have used it in an attempt to increase survival time in irradiated mice.
Experimental. Male CF-1 strain mice, weighing an average of 24 g each, were arranged in groups of 2 0 animals each. Except during irradiation, the animals were maintained in an air-conditioned room at 72 t 5°F and fed a diet of Rockland pellets supplemented weekly with additional vit. A and D. The animals received daily intramuscular injections of 0.36 mg of antibiotic JM-57ht or saline in a total volume of 0.1 ml following the dosage schedules given in Table I and continuing until 90-100% mortality had been attained. An additional non-irradiated antibiotic control group was medicated for 18 days. The 550 r radiation dose was administered from above and below the mice with two 250 KVP Picker Industrial Units operating simultaneously. The technical factors were: 250 KVP; 15 MA; FOD 100 cm; filters, 0.21 mm Cu inherent, 0.5 mm Cu parabolic, and 1.0 mm AL; HVL plastic cage similar to the one previously described for guinea pigs( l l ) . The results obtained were analyzed statistically by the method of Litchfield ( 12).
Upon the basis of the data in Table I , it is evident that, in general, antibiotic JM-57h did not significantly increase the total number of survivors although it had some effect on survival time. Medication throughout the experimental period (Group 6) resulted in a significant increase in the ST50 compared to the saline controls (Group 5). It is also apparent that the animals must be medicated during the first post-irradiation week if any benefit whatsoever is to be obtained (compare Groups 2 and 6 with the balance of the medicated groups). From the infection viewpoint, the first post-irradiation week is critical because the leukocytes are disappearing at a rapid rate while a bacteremia is developing. Vincent and Veomett (13) found that a massive bacteremia from Proteus and Pseudomonas organisms begins during this time interval and Miller et d ( 9 ) made similar observations in the CF-1 mouse. Thus it would appear that after irradiation injury, antibiotic medication with an agent which has a more specific effect on Proteus and Pseudomonas organisms, must be started on the first post-irradiation day and continued for at least 15 days or until the natural body defense mechanisms have recovered their function.
The deaths in the antibiotic treated animals cannot be ascribed to the drug, although the dose used was 0.1 of its LD50 (highest dose tolerated chronicly ) , because there were no deaths or untoward reactions in Group 9. Furthermore, these animals gained an average of 2 g during the experimental period.
Summary. Antibiotic JM-57h, a wide spectrum agent, has been used to combat post-irradiation infection without significantly increasing the total number of survivors. I n Results. 
